Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma
Rue, Sarah M., Eckelman, Brendan P., Efe, Jem A., Bloink, Kristin, Deveraux, Quinn L., Lowery, David, Nasoff, Marc
Published in Veterinary immunology and immunopathology (15.04.2015)
Published in Veterinary immunology and immunopathology (15.04.2015)
Get full text
Journal Article
IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes
Diaz-de-Durana, Yaiza, Lau, Janet, Knee, Deborah, Filippi, Christophe, Londei, Marco, McNamara, Peter, Nasoff, Marc, DiDonato, Michael, Glynne, Richard, Herman, Ann E
Published in PloS one (24.10.2013)
Published in PloS one (24.10.2013)
Get full text
Journal Article
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
Wang, Yan, Engels, Ingo H, Knee, Deborah A, Nasoff, Marc, Deveraux, Quinn L, Quon, Kim C
Published in Cancer cell (01.05.2004)
Published in Cancer cell (01.05.2004)
Get full text
Journal Article
Immunochemical termination of self-tolerance
Grünewald, Jan, Tsao, Meng-Lin, Perera, Roshan, Dong, Liqun, Niessen, Frank, Wen, Ben G, Kubitz, Diane M, Smider, Vaughn V, Ruf, Wolfram, Nasoff, Marc, Lerner, Richard A, Schultz, Peter G
Published in Proceedings of the National Academy of Sciences - PNAS (12.08.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (12.08.2008)
Get full text
Journal Article
Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids
Grünewald, Jan, Hunt, Grady S, Dong, Liqun, Niessen, Frank, Wen, Ben G, Tsao, Meng-Lin, Perera, Roshan, Kang, Mingchao, Laffitte, Bryan A, Azarian, Sassan, Ruf, Wolfram, Nasoff, Marc, Lerner, Richard A, Schultz, Peter G, Smider, Vaughn V
Published in Proceedings of the National Academy of Sciences - PNAS (17.03.2009)
Published in Proceedings of the National Academy of Sciences - PNAS (17.03.2009)
Get full text
Journal Article
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia
Kautz, Léon, Jung, Grace, Du, Xin, Gabayan, Victoria, Chapman, Justin, Nasoff, Marc, Nemeth, Elizabeta, Ganz, Tomas
Published in Blood (22.10.2015)
Published in Blood (22.10.2015)
Get full text
Journal Article
Activation and Suppression of the TRAIL Death-Receptor Pathway in Chemotherapy Sensitive and Resistant Follicular Lymphoma Cells
Wagner, Klaus W., King, Fred, Nomoto, Ken, Knee, Deborah A., Hampton, Garret, Nasoff, Marc, Deveraux, Quinn L.
Published in Cancer biology & therapy (01.09.2003)
Published in Cancer biology & therapy (01.09.2003)
Get full text
Journal Article
Phase 1a/1b study of FOR46, an antibody drug conjugate (ADC), targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC)
Aggarwal, Rahul Raj, Vuky, Jacqueline, VanderWeele, David James, Rettig, Matthew, Heath, Elisabeth I., Beer, Tomasz M., Huang, Jiaoti, Pawlowska, Nela, Sinit, Ryan, Abbey, Jill, Liu, Bin, Nasoff, Marc, Dorr, Andrew, Small, Eric Jay
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
LBY135, a novel anti-DR5 agonistic antibody induces tumor cell-specific cytotoxic activity in human colon tumor cell lines and xenografts
Li, Jing, Knee, Deborah A., Wang, Youzhen, Zhang, Qingxiu, Johnson, Jennifer A., Cheng, Jane, He, Helen, Miller, Christine, Li, Zhifang, Kowal, Colleen, Eckman III, Joseph, Tang, Betty, Yuan, Jing, Chen, Liqing, Deveraux, Quinn, Nasoff, Marc S., Stover, David
Published in Drug development research (01.03.2008)
Published in Drug development research (01.03.2008)
Get full text
Journal Article
P-225: A first-in-human study of FOR46 in patients with triple refractory Multiple Myeloma
Wong, Sandy, Imus, Philip, Mark, Tomer, Kaufman, Jonathan, Imus, Ajai, Zonder, Jeffrey A., Walker, Zachary, Sherbenou, Daniel, Schroeder, Mark, Abbey, Jill, Nasoff, Marc, Dorr, Andrew, Liu, Bin, Martin, Thomas
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Get full text
Journal Article
1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors
Salek-Ardakani, Shahram, DiRaimondo, Thomas, Budimir, Natalija, Ma, Lina, Shenhav, Simon, Cicchini, Vanessa, Wu, Hua, Jocic, Renee, Roup, Fabrece, Cambell, Calvin, Caffaro, Carolina, Aerni, Hans, Eskiocak, Ugur, Godfrey, Wayne, Winter, Charles, Nasoff, Marc, Gibson, Neil, Campbell, David
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article